Search

Showing total 102 results

Search Constraints

Start Over You searched for: Journal science & public policy (spp) Remove constraint Journal: science & public policy (spp) Region united states Remove constraint Region: united states Publisher oxford university press / usa Remove constraint Publisher: oxford university press / usa
102 results

Search Results

1. The US Federal Trade Commission’s Line of Business Program and innovation research.

2. Introduction to a special issue: New insights on EU--US comparison of corporate R&D.

3. Institutional persistence through gradual organizational adaptation: Analysis of national laboratories in the USA and Germany.

4. The uneven spread of global science: patterns of international collaboration in global environmental change research.

5. Congress’s own think tank: Learning from the legacy of the Office of Technology Assessment (1972–95).

6. The origins of human embryonic stem cell research policies in the US states.

7. The cross-state distribution of federal funding in the USA: The case of financing academic research and development.

8. European competitiveness in information technology and long-term scientific performance.

9. Financing constraints and R&D investments of large corporations in Europe and the US.

10. R&D in services industries and the EU--US R&D investment gap.

11. University spin-off firms: lessons from ten years of experience in Europe.

12. Principal-agent theory and the structure of science policy, revisited: 'science in policy' and the US Report on Carcinogens.

13. The unintended effect of the Orphan Drug Act on the adoption of open innovation.

14. Individual inventors and market potentials: Evidence from US patents.

15. Introduction to special issue on learning, innovation systems and policy in honour of Bengt-Åke Lundvall.

16. An agent, not a mole: Assessing the White House Office of Science and Technology Policy.

17. The returns to R&D: Division of Policy Research and Analysis at the National Science Foundation.

18. Regulation of pesticides: A comparative analysis*.

19. The impact of empowering scientific advisory committees to constrain catch limits in US fisheries.

20. Understanding shifting perceptions of nanotechnologies and their implications for policy dialogues about emerging technologies.

21. Opportunities for impact: Statistical analysis of the National Science Foundation's broader impacts criterion.

22. State stem cell policy and the geographic preferences of scientists in a contentious emerging field.

23. A referral is worth a thousand ads: Job search methods and scientist outcomes in the market for postdoctoral scholars.

24. Business R&D in the ICT sector: examining the European ICT R&D deficit.

25. Patent reform in Europe and the US.

26. The National Citizens' Technology Forum: lessons for the future.

27. Pathways to the entrepreneurial university: towards a global convergence.

28. 'Iraqi Winnebagos of death': imagined and realized futures of US bioweapons threat assessments.

29. Quantitative portfolio evaluation of US federal research and development programs.

30. Governing human subjects research in the USA: individualized ethics and structural inequalities.

31. An analysis of efforts to improve genetically modified food regulation in Canada.

32. The US National Bioethics Advisory Commission as a boundary organization.

33. Science and democracy in a globalizing world: challenges for American foreign policy.

34. Democracy in the age of assessment: reflections on the roles of expertise and democracy in public-sector decision making.

35. (No?) Accounting for expertise.

36. The co-development of industrial sectors and academic disciplines.

37. The electronic Scientific Portfolio Assistant: Integrating scientific knowledge databases to support program impact assessment.

38. EU--US differences in the size of R&D intensive firms: do they explain the overall R&D intensity gap?

39. The entrepreneurial university in China: nonlinear paths.

40. Approaches to research and development performance assessment in the United States: an analysis of recent evaluation trends.

41. Investigating the US biomedical workforce: Gender, field of training, and retention.

43. Comparing the collaboration networks and productivity of China-born and US-born academic scientists.

44. Plans versus experiences in transitioning transnational education into research and economic development: a case study.

45. Inventor mobility and the geography of knowledge flows: evidence from the US biopharmaceutical industry.

46. Market failure in the diffusion of clinician-developed innovations: The case of off-label drug discoveries.

47. Perceived career prospects and their influence on the sector of employment of recent PhD graduates.

48. The new model innovation agencies: An overview.

49. On the social value of quality: An economic evaluation of the Baldrige Performance Excellence Program.

50. Institutional persistence and the material transformation of the US national labs: The curious story of the advent of the Advanced Photon Source.